MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Kang, B. W. [1 ]
Kim, J. G. [1 ]
Chae, Y. S. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Lee, W. S. [3 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Dongsan Med Ctr, Taegu, South Korea
[3] Daegu Fatima Hosp, Ctr Canc, Taegu, South Korea
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] MGMT-535G>T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kim, J. G. K.
    Choi, G. S. C.
    Chung, H. Y. C.
    Jun, S. H. J.
    Lim, K. H. L.
    Kang, B. W. K.
    Jeon, S. W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : I35 - I35
  • [2] MGMT-535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Park, Jee Hyun
    Kim, Nung Soo
    Park, Jae Yong
    Chae, Yee Soo
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kang, Byung Woog
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Choi, Gyu Seog
    Jun, Soo-Han
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1135 - 1142
  • [3] Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
    Chae, Y.
    Kim, J.
    Sohn, S.
    Kang, B.
    Ryoo, H.
    Bae, S.
    Choi, G.
    Baek, J.
    Kim, Y.
    Cho, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Jee Hyun Park
    Nung Soo Kim
    Jae Yong Park
    Yee Soo Chae
    Jong Gwang Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Byung Woog Kang
    Hun Mo Ryoo
    Sung Hwa Bae
    Gyu Seog Choi
    Soo-Han Jun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1135 - 1142
  • [5] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [6] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Le Charpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 460 - 466
  • [7] Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Choi, Ji Hoon
    Shin, Jung A.
    Park, Hye Kyeong
    Kim, Su Young
    Jung, Hoon
    Lee, Sung-Soon
    Lee, Hye Ran
    Koo, Hyeon-Kyoung
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [8] Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy
    Park, Hanla A.
    Seibold, Petra
    Edelmann, Dominic
    Benner, Axel
    Canzian, Federico
    Alwers, Elizabeth
    Jansen, Lina
    Schneider, Martin
    Hoffmeister, Michael
    Brenner, Hermann
    Chang-Claude, Jenny
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (02) : 352 - 361
  • [9] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [10] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
12345